Suppr超能文献

心脏组织26S蛋白酶体活性的最佳测定需要最大刺激ATP浓度。

Optimal determination of heart tissue 26S-proteasome activity requires maximal stimulating ATP concentrations.

作者信息

Powell Saul R, Davies Kelvin J A, Divald Andras

机构信息

The Feinstein Institute for Medical Research, Long Island Jewish Medical Center Campus, New Hyde Park, NY 11042, USA.

出版信息

J Mol Cell Cardiol. 2007 Jan;42(1):265-9. doi: 10.1016/j.yjmcc.2006.10.010. Epub 2006 Nov 30.

Abstract

The ubiquitin-proteasome system has been implicated in both cardiac physiology and pathophysiology. Research in this area has been hampered by the lack of a simple, reproducible method to assess 26S-proteasome peptidase activities. The current report demonstrates that one reason for lack of reproducibility is the myriad of ATP concentrations, many of them excessive, which have been used to stimulate peptidase activity. The chymotrypsin-like or caspase-like activities of 26S-proteasome in cardiac tissue isolates were determined using Suc-LLVY-AMC or Z-LLE-AMC, respectively, over a range of ATP concentrations up to 2 mmol/L. The optimal ATP concentration to assess both peptidase activities was found to be in the low micromolar range (from 6 to 100 micromol/L) depending on the cardiac tissue isolate protein (10 to 90 microg protein) contained in the reaction. Increasing ATP beyond the optimal range was inhibitory. In general, chymotrypsin-like and caspase-like activities could be stimulated 2- to 2.5-fold and 1.4- to 1.8-fold, respectively, over basal (ATP, 0 micromol/L), and could be effectively inhibited with lactacystin or Z-Pro-Nle-Asp-CHO, respectively. Based on these observations, an optimized method is presented for ex vivo determination of cardiac 26S-proteasome peptidase activities which was used to confirm inactivation of this complex by myocardial ischemia and reperfusion.

摘要

泛素-蛋白酶体系统与心脏生理和病理生理均有关联。该领域的研究因缺乏一种简单、可重复的方法来评估26S蛋白酶体的肽酶活性而受到阻碍。本报告表明,缺乏可重复性的一个原因是用于刺激肽酶活性的ATP浓度众多,其中许多浓度过高。使用Suc-LLVY-AMC或Z-LLE-AMC分别在高达2 mmol/L的一系列ATP浓度下测定心脏组织分离物中26S蛋白酶体的类胰凝乳蛋白酶样或类半胱天冬酶样活性。发现评估这两种肽酶活性的最佳ATP浓度处于低微摩尔范围(6至100微摩尔/升),这取决于反应中所含心脏组织分离物蛋白(10至9微克蛋白)。将ATP浓度增加到超出最佳范围具有抑制作用。一般而言,类胰凝乳蛋白酶样和类半胱天冬酶样活性分别可比基础水平(ATP,0微摩尔/升)刺激2至2.5倍和1.4至1.8倍,并且可分别被乳胞素或Z-Pro-Nle-Asp-CHO有效抑制。基于这些观察结果,提出了一种用于离体测定心脏26S蛋白酶体肽酶活性的优化方法,该方法用于证实心肌缺血和再灌注对该复合物的失活作用。

相似文献

1
Optimal determination of heart tissue 26S-proteasome activity requires maximal stimulating ATP concentrations.
J Mol Cell Cardiol. 2007 Jan;42(1):265-9. doi: 10.1016/j.yjmcc.2006.10.010. Epub 2006 Nov 30.
2
Activation of Chymotrypsin-Like Activity of the Proteasome during Ischemia Induces Myocardial Dysfunction and Death.
PLoS One. 2016 Aug 16;11(8):e0161068. doi: 10.1371/journal.pone.0161068. eCollection 2016.
3
Regulation of the proteasome by ATP: implications for ischemic myocardial injury and donor heart preservation.
Am J Physiol Heart Circ Physiol. 2013 Aug 1;305(3):H267-78. doi: 10.1152/ajpheart.00206.2012. Epub 2013 May 24.
4
Inhibitory effect of flavonoids on 26S proteasome activity.
J Agric Food Chem. 2009 Oct 28;57(20):9706-15. doi: 10.1021/jf9017492.
7
Role of ginsenoside Rd in inhibiting 26S proteasome activity.
J Agric Food Chem. 2008 Dec 24;56(24):12011-5. doi: 10.1021/jf801427e.
8
The ubiquitin-proteasome proteolytic pathway in heart vs skeletal muscle: effects of acute diabetes.
Biochem Biophys Res Commun. 2000 Oct 5;276(3):1255-60. doi: 10.1006/bbrc.2000.3609.
9
Physiological levels of ATP negatively regulate proteasome function.
Cell Res. 2010 Dec;20(12):1372-85. doi: 10.1038/cr.2010.123. Epub 2010 Aug 31.
10
5,6,3',4'-Tetrahydroxy-7-methoxyflavone as a novel potential proteasome inhibitor.
Planta Med. 2010 Jul;76(10):987-94. doi: 10.1055/s-0029-1240899. Epub 2010 Mar 1.

引用本文的文献

1
Myocardial Protection and Current Cancer Therapy: Two Opposite Targets with Inevitable Cost.
Int J Mol Sci. 2022 Nov 15;23(22):14121. doi: 10.3390/ijms232214121.
3
Proteasome Biology: Chemistry and Bioengineering Insights.
Polymers (Basel). 2020 Dec 4;12(12):2909. doi: 10.3390/polym12122909.
5
Increased AMP deaminase activity decreases ATP content and slows protein degradation in cultured skeletal muscle.
Metabolism. 2020 Jul;108:154257. doi: 10.1016/j.metabol.2020.154257. Epub 2020 May 1.
6
Loss of Asb2 Impairs Cardiomyocyte Differentiation and Leads to Congenital Double Outlet Right Ventricle.
iScience. 2020 Mar 27;23(3):100959. doi: 10.1016/j.isci.2020.100959. Epub 2020 Mar 4.
7
Renal cold storage followed by transplantation impairs proteasome function and mitochondrial protein homeostasis.
Am J Physiol Renal Physiol. 2019 Jan 1;316(1):F42-F53. doi: 10.1152/ajprenal.00316.2018. Epub 2018 Oct 10.
8
Inhibiting autophagy reduces retinal degeneration caused by protein misfolding.
Autophagy. 2018;14(7):1226-1238. doi: 10.1080/15548627.2018.1463121. Epub 2018 Jul 13.
9
Upregulation of PSMB8 and cathepsins in the human brains of dementia with Lewy bodies.
Neurosci Lett. 2018 Jun 21;678:131-137. doi: 10.1016/j.neulet.2018.05.022.
10
Proteostasis in cardiac health and disease.
Nat Rev Cardiol. 2017 Nov;14(11):637-653. doi: 10.1038/nrcardio.2017.89. Epub 2017 Jun 29.

本文引用的文献

1
The ubiquitin-proteasome system in cardiac physiology and pathology.
Am J Physiol Heart Circ Physiol. 2006 Jul;291(1):H1-H19. doi: 10.1152/ajpheart.00062.2006. Epub 2006 Feb 24.
2
Impairment of the ubiquitin-proteasome system in desminopathy mouse hearts.
FASEB J. 2006 Feb;20(2):362-4. doi: 10.1096/fj.05-4869fje. Epub 2005 Dec 21.
3
Proteasome mediates removal of proteins oxidized during myocardial ischemia.
Free Radic Biol Med. 2006 Jan 1;40(1):156-64. doi: 10.1016/j.freeradbiomed.2005.09.022. Epub 2005 Oct 17.
4
Monitoring activity and inhibition of 26S proteasomes with fluorogenic peptide substrates.
Methods Enzymol. 2005;398:364-78. doi: 10.1016/S0076-6879(05)98030-0.
5
Purification of PA700, the 19S regulatory complex of the 26S proteasome.
Methods Enzymol. 2005;398:295-306. doi: 10.1016/S0076-6879(05)98024-5.
8
Cardioprotection with palm tocotrienol: antioxidant activity of tocotrienol is linked with its ability to stabilize proteasomes.
Am J Physiol Heart Circ Physiol. 2005 Jul;289(1):H361-7. doi: 10.1152/ajpheart.01285.2004. Epub 2005 Feb 11.
9
In situ dynamically monitoring the proteolytic function of the ubiquitin-proteasome system in cultured cardiac myocytes.
Am J Physiol Heart Circ Physiol. 2004 Sep;287(3):H1417-25. doi: 10.1152/ajpheart.01233.2003. Epub 2004 Apr 22.
10
Assessment of proteasome activity in cell lysates and tissue homogenates using peptide substrates.
Int J Biochem Cell Biol. 2003 May;35(5):716-27. doi: 10.1016/s1357-2725(02)00391-6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验